Immutep, Percheron and PYC feature in clinical trial updates Control Bionics guides to higher revenue, despite ongoing NDIS delays Botanix dispatches its first US prescriptions for its anti-sweat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback